Control and variability of gastric pH in critically ill children

Crit Care Med. 1993 Dec;21(12):1850-5. doi: 10.1097/00003246-199312000-00011.

Abstract

Objectives: To determine the effect of illness severity and acute central nervous system injury on the control and variability of gastric pH in pediatric intensive care unit (ICU) patients receiving ranitidine.

Design: Prospective, descriptive study.

Setting: Pediatric ICU of a children's hospital.

Patients: Fourteen pediatric ICU patients.

Interventions: Ranitidine (4 mg/kg/day) was administered to all patients.

Measurements and main results: Patients enrolled in the study were divided into two groups based on illness type and severity. Illness severity was measured by the Pediatric Risk of Mortality (PRISM) score, with a PRISM score of > or = 20 defining severe illness. Illness type was designated as central nervous system or noncentral nervous system. Gastric pH was continuously monitored in all patients using an intragastric, pH-sensitive electrode. Poor control of gastric pH was defined as a pH of < 4.0 for > 20% of the time monitored. The statistical significance of the differences between groups was measured using the Wilcoxon two-sample test or Fisher's exact test. Patients with severe illness or acute central nervous system injury had a lower mean gastric pH than all other patients (4.6 vs. 6.4; p = .008) and spent more time with a gastric pH of < 4.0 than other patients (47.5% of time monitored vs. 12.5% of time monitored; p = .003). Poor control of gastric pH occurred in 100% of patients with severe illness or acute central nervous system injury, while only 20% of the remaining patients had poor control of gastric pH (p = .01). Using power-spectrum analysis to evaluate gastric pH variability, gastric pH in patients receiving bolus ranitidine was more variable than gastric pH in patients receiving ranitidine continuously (p = .045). Illness severity or type had no effect on gastric pH variability (p = .78).

Conclusions: a) Continuous infusion of ranitidine decreases variability of gastric pH in pediatric ICU patients; b) gastric pH variability may make intermittent monitoring of gastric pH inaccurate; c) children with acute central nervous system injury or PRISM scores of > or = 20 have poor control of gastric pH; d) type of injury and PRISM scores predict response to ranitidine therapy.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Central Nervous System Diseases / classification
  • Central Nervous System Diseases / complications*
  • Central Nervous System Diseases / mortality
  • Child
  • Child, Preschool
  • Fourier Analysis
  • Gastric Acid / metabolism*
  • Gastric Acidity Determination
  • Gastrointestinal Hemorrhage / drug therapy*
  • Gastrointestinal Hemorrhage / etiology
  • Gastrointestinal Hemorrhage / prevention & control
  • Humans
  • Hydrogen-Ion Concentration
  • Infant
  • Infusions, Intravenous
  • Injections, Intravenous
  • Intensive Care Units, Pediatric
  • Monitoring, Physiologic
  • Ranitidine / pharmacology
  • Ranitidine / therapeutic use*
  • Risk Factors
  • Severity of Illness Index*

Substances

  • Ranitidine